Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood

Assignee

• Inserm (Institut National De La Santé Et De La Recherche Médicale)
• Universite De Droit Et De La Sante De Lille 2
• Centre Hospitalier Regional Et Universitaire De Lille (Chru)

Inventors

• Philippe Lassalle (2 patents)

View full patent text on Google Patents →